CHAIR
:
SPEAKER
(S):
Pradeep Kumar Bhatnagar
Swati Piramal
Rashmi Barbhaiya, PhD, Chief Executive Officer & Managing Director, Advinus Therapeutics
Maharaj Krishan Bhan, Secretary, Department of Biotechnology, Ministry of Science & Technology
Ramesh Adige, Executive Director, Ranbaxy Laboratories Limited
M Vidyasagar, Executive Vice President, Tata Consultancy Services
Description
India is rapidly attaining critical mass in terms of biotech skills and capabilities to become a truly global player. The session will talk about the emerging positive changes in India such as compliance of product patent as per the TRIPS agreement, emerging strength in innovation-driven R&D, availability of a large talent pool coupled with the obvious cost-effectiveness advantage, etc.
Objectives:
Highlight India's prowess in the area of biotechnology: skills, capacity, competence and excellence.
Discuss the legal framework and infrastructural development of India in complementing the biotechnology industry growth.
Highlight India's success in competing globally in fundamental science, research and development, manufacturing and trade in life sciences.